大庆华科(000985) - 2020 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2020 was ¥451,505,707.61, a decrease of 14.75% compared to ¥529,599,295.80 in the same period last year[7] - The net profit attributable to shareholders was -¥24,580,451.49, representing a decline of 417.64% from ¥7,738,424.12 in the previous year[7] - The net cash flow from operating activities was -¥41,683,402.37, a significant drop of 360.29% compared to ¥16,237,186.20 in the same period last year[7] - The total comprehensive income for Q1 2020 was -24,580,451.49 CNY, compared to 7,738,424.12 CNY in Q1 2019, reflecting a substantial decline in overall financial performance[27] - The company expects a net loss of ¥29 million to ¥37 million for the first half of 2020, representing a decline of 238.36% compared to the previous year[18] - Basic earnings per share are projected to be -¥0.285, a decrease of 238.35% from -¥0.224 in the same period last year[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥695,154,955.62, down 6.19% from ¥741,035,161.69 at the end of the previous year[7] - Total assets decreased to ¥695.15 million from ¥741.04 million, indicating a reduction in overall company size[21] - Total liabilities decreased to ¥139.41 million from ¥162.91 million, showing a decrease in financial obligations[23] - Total assets amounted to CNY 741,035,161.69, with current assets at CNY 298,759,694.72 and non-current assets at CNY 442,275,466.97[32] - Total liabilities were CNY 162,912,483.16, consisting of current liabilities of CNY 115,744,692.71 and non-current liabilities of CNY 47,167,790.45[32] Cash Flow and Liquidity - The net increase in cash and cash equivalents was a negative ¥44.81 million, a decline of 99014.39% from a positive ¥45,304.90 in the previous period[17] - The company's cash and cash equivalents decreased from ¥220.67 million to ¥175.85 million, indicating liquidity challenges[21] - The total cash and cash equivalents at the end of Q1 2020 were 175,273,089.77 CNY, a decrease from 175,486,500.03 CNY at the end of Q1 2019[30] - The cash outflow from investing activities in Q1 2020 was -2,549,664.77 CNY, compared to -16,191,881.30 CNY in the same period last year, indicating an improvement in cash flow management[30] Operational Challenges - The company faced significant operational losses due to the impact of COVID-19 and fluctuations in international oil prices[15] - Cash received from sales and services decreased by 22.71% to ¥473.72 million compared to ¥612.88 million in the previous period[17] - Operating profit for Q1 2020 was -24,694,751.49 CNY, a decrease from the operating profit of 7,780,059.59 CNY in Q1 2019[26] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,929[9] - The top shareholder, China Petroleum Daqing Oilfield Chemical Co., Ltd., held 39.34% of the shares, totaling 51,000,000 shares[9] Impairment and Expenses - The company reported an asset impairment loss of -¥6,252,760.13, a dramatic increase of 3190.21% compared to -¥190,041.33 in the previous year[15] - Research and development expenses for Q1 2020 were 2,151,540.95 CNY, down from 2,605,499.09 CNY in the previous year, showing a reduction of about 17.4%[26] Reporting and Governance - The first quarter report has not been audited[34] - The report was presented by Chairman Xu Yongning on April 16, 2020[35]